← FDA Drug Approvals (Drugs@FDA)

IRINOTECAN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HISUN PHARM HANGZHOU · Approved 2009-01-28

Drug application

FDA Application #

ANDA090016

Application type

Abbreviated New Drug Application (Generic)

Brand name

IRINOTECAN HYDROCHLORIDE

Generic name

Irinotecan Hydrochloride

Active ingredients

IRINOTECAN HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

HISUN PHARM HANGZHOU

First approval

2009-01-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown